Meanwhile, SREBP-1c plays a pivotal role in the development and pathogenesis of NAFLD [36], and the downregulation of SREBP-1c reportedly suppressed de novo fatty acid synthesis in fatty acid overload [37]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.